Apella Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.59M Buy
56,927
+10,327
+22% +$275K 0.02% 310
2026
Q2
$1.12M Sell
46,600
-3,043
-6% -$79.6K 0.02% 349
2026
Q1
$1.37M Buy
49,643
+22,229
+81% +$592K 0.02% 315
2025
Q4
$683K Buy
27,414
+2,750
+11% +$69.3K 0.01% 314
2025
Q3
$598K Buy
24,664
+1,813
+8% +$44.7K 0.01% 302
2025
Q2
$577K Buy
22,851
+249
+1% +$5.81K 0.02% 281
2025
Q1
$508K Buy
22,602
+1,374
+6% +$36K 0.02% 254
2024
Q4
$563K Buy
21,228
+3,035
+17% +$82.3K 0.02% 219
2024
Q3
$520K Buy
18,193
+582
+3% +$17K 0.02% 213
2024
Q2
$488K Buy
17,611
+2,858
+19% +$78.7K 0.02% 208
2024
Q1
$395K Sell
14,753
-461
-3% -$12.8K 0.02% 213
2023
Q4
$443K Sell
15,214
-182
-1% -$5.5K 0.02% 197
2023
Q3
$511K Sell
15,396
-475
-3% -$16.8K 0.04% 168
2023
Q2
$582K Buy
+15,871
New +$618K 0.04% 162
2022
Q4
$919K Buy
17,932
+2,130
+13% +$102K 0.08% 113
2022
Q3
$692K Buy
15,802
+543
+4% +$26.4K 0.08% 110
2022
Q2
$800K Buy
15,259
+1,054
+7% +$53.7K 0.1% 110
2022
Q1
$735K Buy
14,205
+132
+0.9% +$6.85K 0.1% 106
2021
Q4
$831K Buy
14,073
+460
+3% +$22.8K 0.11% 97
2021
Q3
$585K Buy
13,613
+11
+0.1% +$487 0.08% 125
2021
Q2
$533K Sell
13,602
-218
-2% -$8.48K 0.09% 133
2021
Q1
$501K Sell
13,820
-85
-0.6% -$3.02K 0.16% 82
2020
Q4
$512K Sell
13,905
-1,120
-7% -$41.1K 0.18% 82
2020
Q3
$523K Buy
15,025
+501
+3% +$17.6K 0.21% 79
2020
Q2
$451K Buy
14,524
+7,448
+105% +$253K 0.21% 83
2020
Q1
$219K Buy
+7,076
New +$241K 0.13% 97

Other funds holding PFE

Apella Capital's PFE Position: Q3 2026 in Review

Apella Capital increased its Pfizer (PFE) stake by 22% in Q3 2026, buying an estimated $275K and bringing the position to 56,927 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #310.

Apella Capital first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Apella Capital held 56,927 shares of Pfizer worth $1.59M as of Q3 2026.
  • Apella Capital bought 10,327 Pfizer shares in Q3 2026, an estimated $275K.
  • Pfizer made up 0.02% of Apella Capital's portfolio in Q3 2026, its #310 holding.
  • Apella Capital first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.